stockrowCastle Biosciences, Inc. (CSTL) vs Fulgent Genetics, Inc. (FLGT)
- Castle Biosciences, Inc. CSTL 34.16 −4.45%
- Fulgent Genetics, Inc. FLGT 18.66 −5.18%
Castle Biosciences, Inc. and Fulgent Genetics, Inc. are both Diagnostics & Research companies. Castle Biosciences, Inc. is the larger, with a market value of $1.0B against $513.4M — 2.0× the size. Castle Biosciences, Inc. grew revenue faster over the last twelve months: 9.78% against 4.67%. Castle Biosciences, Inc. has the higher net margin (−6.10% vs −27.5%) and the higher return on invested capital (−3.63% vs −8.22%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 10 and Fulgent Genetics, Inc. on 8.
Valuation
Profitability
| Metric | CSTL | FLGT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 77.07% | 33.82% | 48.32% |
| Operating margin | (7.43%) | (39.20%) | (5.68%) |
| Net margin | (6.10%) | (27.53%) | (4.10%) |
| Free cash flow margin | 1.06% | 4.37% | 0.00% |
| Return on equity | (4.87%) | (8.64%) | 0.00% |
| Return on assets | (4.03%) | (7.93%) | (6.05%) |
| Return on invested capital | (3.63%) | (8.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack